Clinical Trials on Loss of Face Volume in Australia

Total 15 results

Allergan

Completed

Safety and Efficacy of Juvederm® VOLUMA™ for Correction of Mid-face Volume Deficiency

Mid-face Volume Deficiency

Australia
Croma-Pharma GmbH
Proinnovera GmbH

Completed

THIODERM STRONG Compared to Juvéderm® VOLUMA® Lidocaine for the Treatment of Midface Volume Deficit (TIMI)

Mid Face Volume Deficit

Austria
Medical University of Vienna

Completed

Bone Metabolism After Laparoscopic Gastric Bypass Surgery (BABS) (BABS)

Evaluation of Expected Bone Loss After Bariatric Surgery | Possible Prevention of Bone Loss After Surgery by Calcium and Vitamin D Supplementation

Austria
Dominik Riss

Completed

Audiological Benefit and Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Contact Mini

Conductive Hearing Loss

Austria
Medical University of Vienna

Recruiting

Quality of Life With Bone Conduction Hearing Device

Conductive Hearing Loss

Austria
Croma-Pharma GmbH

Completed

Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars (FLASH2)

Facial Lipoatrophy | Morphological Asymmetry of the Face | Debilitating Scars

Austria
Croma-Pharma GmbH

Completed

Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars (FLASH 1)

Facial Lipoatrophy | Morphological Asymmetry of the Face | Debilitating Scars

Austria
Ology Bioservices

Completed

Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801

Prophylaxis of Ross River Virus Infection

Australia
Dominik Riss

Completed

Audiological Benefit and Improved Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Bonebridge in Experienced Users

Hearing Loss, Conductive | Bone Conduction Deafness

Austria
Ology Bioservices

Completed

Ross River Virus (RRV) Vaccine Study

Prophylaxis of Ross River Virus Infection

Australia
Medical University Innsbruck

Not yet recruiting

Olfactory Training in COVID-19 Associated Loss of Smell

COVID-19 | Hyposmia

Austria
Zimmer Biomet

Recruiting

Clinical Outcomes Study of the Nexel Total Elbow

Post-traumatic Arthritis | Degenerative Arthritis | Elbow Joint Destruction | Post-traumatic Lesions | Ankylosed Joints | Advanced Rheumatoid Arthritis | Joint Instability or Loss of Motion | Acute Comminuted Articular Fracture of Elbow Joint Surfaces | Bone Loss Contributing to Elbow Instability | Bilateral...

United States, Australia, Finland, France, Germany, Italy, Netherlands, United Kingdom
NHS Lothian

Completed

The Management of Transient Loss of Consciousness and Suspected Syncope in European Emergency Departments (SEED)

Syncope

France, Spain, United Kingdom, Belgium, Norway, Czechia, Denmark, Greece, Albania, Austria, Finland, Hungary, Italy, Malta, Poland, Romania, Serbia, Turkey
Pfizer

Active, not recruiting

Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 (PROACC-1)

Fatigue | Colorectal Cancer | Pancreatic Cancer | Cachexia | Non-small Cell Lung Cancer | Loss of Appetite

China, United States, Canada, Hungary, Australia, Slovakia, Japan, Taiwan, Bulgaria, Poland, Spain, Czechia
Sanford Health
National Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaborators

Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)

Mitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditions

United States, Australia

Clinical Trials on Loss of Face Volume in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations